No Data
No Data
Metagenomi, Inc. (MGX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
H.C. Wainwright Maintains Metagenomi Technologies, LLC(MGX.US) With Buy Rating, Maintains Target Price $10
Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
Express News | HC Wainwright & Co. Reiterates Buy on Metagenomi, Maintains $10 Price Target
Express News | Metagenomi Technologies LLC : Jefferies Cuts Target Price to $21 From $22
Express News | Metagenomi Q1 2024 Adj EPS $(1.19) Misses $(0.78) Estimate
No Data